Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5. This indicates a minor, internal update to the page version rather than a substantive change to study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T23:52:05.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a new revision of the page. This update appears to reflect minor internal changes to the page rather than new or altered study information.
    Difference
    0.0%
    Check dated 2026-07-25T16:59:48.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a newer version of the page content. This appears to be a maintenance update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T13:09:10.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous v3.6.0 on the page, signaling an update to the study record. This reflects a version change rather than a substantive alteration to study details.
    Difference
    0.0%
    Check dated 2026-06-27T07:40:24.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page now displays a 'No longer looking for participants' notice and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to help users navigate the study details. The Intervention/Treatment header formatting is updated and the prior Revision label (v3.5.5) was removed, reflecting a styling and version update.
    Difference
    0.5%
    Check dated 2026-06-13T04:31:13.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Revision identifier updated from v3.5.4 to v3.5.5, indicating a newer build of the page. This likely reflects minor updates or fixes rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T22:19:20.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.